Life Insurance with Interstitial Lung Disease in 2026

Yes, interstitial lung disease affects your life insurance rates. The condition signals ongoing lung tissue inflammation or scarring that carriers view as progressive respiratory risk. But approval is not the question here. The question is which carrier rates your specific ILD situation most favorably, because the difference between a good match and a poor match can mean paying double for the same coverage amount.

Why Interstitial Lung Disease Affects Your Rates

Underwriters evaluate ILD through the lens of progression risk and respiratory function decline. The interstitial tissue in your lungs affects oxygen exchange, and most forms of ILD worsen over time despite treatment. Carriers need to assess how quickly that decline happens and how well your current treatment controls symptoms.

The specific diagnosis matters enormously. Idiopathic pulmonary fibrosis carries the worst prognosis and highest ratings. Hypersensitivity pneumonitis from a removed environmental exposure rates better. Sarcoidosis in remission rates better still. When we help clients with ILD, the first question is always which type, because that sets the baseline for everything else.

Your pulmonary function tests provide the objective measurements underwriters use. An FVC (forced vital capacity) above 70% of predicted positions you much better than someone at 50%. DLCO (diffusing capacity) numbers matter just as much. These metrics, combined with your six minute walk test results and oxygen saturation levels, create the statistical profile carriers use for classification.

What Underwriters Actually Evaluate

The underwriting checklist for interstitial lung disease focuses on these specific factors:

Your exact ILD diagnosis. Idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, cryptogenic organizing pneumonia, hypersensitivity pneumonitis, and sarcoidosis all carry different risk profiles. The “idiopathic” forms (unknown cause) generally rate worse than ILD with identified and removed triggers.

Current pulmonary function test results. Your most recent PFT numbers, particularly FVC and DLCO percentages. Results above 70% predicted put you in significantly better classification territory than results below 50%. The trend matters too. Stable numbers over 12 to 24 months help considerably.

Oxygen requirements. Room air versus supplemental oxygen makes a table rating difference of 4 to 6 classes. If you need oxygen only with exertion versus at rest also factors into the equation. Continuous oxygen use typically pushes applications toward guaranteed issue territory.

Medication regimen. Corticosteroids alone versus immunosuppressants versus antifibrotic medications (pirfenidone or nintedanib) tell underwriters about disease severity. Multiple medications signal more aggressive disease requiring stronger intervention.

Time since diagnosis and progression rate. Someone diagnosed 18 months ago with minimal decline rates better than someone diagnosed 5 years ago who has lost 30% lung capacity. Recent diagnosis with aggressive decline is worst case scenario.

Functional capacity and hospitalizations. Can you work? Do you have activity restrictions? Any hospitalizations or ER visits for respiratory distress in the past 24 months? These functional measures often matter more than the diagnosis itself.

How Table Ratings Work in Real Dollars

Life insurance table ratings add 25% to your premium for each table. Table 1 means 25% above standard rates. Table 2 means 50% above standard. Table 4 means 100% above standard (double the cost).

Put into actual numbers, a healthy 45 year old male might pay $55 per month for $500,000 of 20 year term coverage at standard rates. That same person with interstitial lung disease might see these scenarios:

Mild ILD with stable PFTs above 70% and no oxygen needs: Table 2 to Table 4 range, putting monthly premiums around $80 to $110.

Moderate ILD with PFTs between 50% to 70% and oxygen use with exertion: Table 6 to Table 8 range, putting monthly premiums around $135 to $165.

Advanced ILD with PFTs below 50% or resting oxygen requirements: Table 10 or higher, or potentially guaranteed issue only options.

These numbers show why positioning your application correctly matters. A three table difference on a $500,000 policy over 20 years means roughly $18,000 in additional premium costs. That money either stays in your pocket or goes to the insurance carrier, depending on how well you shop the market.

The Independent Agency Advantage

This is where interstitial lung disease cases separate into good outcomes versus expensive outcomes. Different carriers rate the same ILD profile with shocking variation. One carrier might put stable sarcoidosis at Table 2 while another assigns Table 5 to an identical application. A client with hypersensitivity pneumonitis from removed mold exposure might get Table 3 from carrier A and Table 6 from carrier B.

The rating differences stem from each carrier’s claim experience with respiratory conditions and their specific underwriting guidelines for ILD subtypes. Some carriers weight PFT trends heavily. Others focus more on medication requirements. A few have favorable programs for specific ILD forms based on recent mortality studies.

We shop your profile across dozens of carriers specifically to find these favorable matches. Insurance By Heroes was founded by a former first responder and military spouse, and every member of our team comes from a public service background. That service first mentality means we treat your case with the same thoroughness we’d demand for our own families. We apply that elite level of care to everyone, regardless of background, because protecting your family requires the same duty and diligence whether you’re a teacher, accountant, or fellow veteran.

As an independent agency, we compare policies from many different carriers rather than being locked into one company’s underwriting guidelines. That comparison shopping is what turns a Table 6 offer into a Table 3 approval.

Positioning Your Application for the Best Outcome

Several factors consistently improve table ratings for ILD applicants:

Stable or slowly progressive disease. If your PFTs show minimal decline over 18 to 24 months, gather those reports. Stability is the single biggest factor that moves ratings downward. Two years of test results showing FVC holding steady at 72% beats a single recent test at 75%.

Treatment compliance and regular monitoring. Consistent pulmonology follow up every 3 to 6 months with documented medication compliance demonstrates you’re managing the condition properly. Missed appointments or gaps in treatment raise red flags about progression risk.

Known cause ILD versus idiopathic. If your ILD stems from an identifiable and removed exposure (certain medications, environmental hazards, occupational dust), make sure that causation and removal is clearly documented. This rates significantly better than unknown cause fibrosis.

Good functional status. If you’re still working full time, document that. If you maintain normal activities without significant limitations, have your pulmonologist note functional capacity in their records. Underwriters view functional independence as a proxy for disease severity.

Recent imaging and testing. Applications submitted with PFTs, six minute walk tests, and chest CT results from within the past 6 months rate better than applications requiring the carrier to order updated testing. Current data speeds the process and often yields better classifications.

The timing question comes up frequently. Should you wait until your condition stabilizes more? Usually no. Waiting means you get older, and age itself increases premiums roughly 8% to 10% per year in your 40s and 50s. Waiting also risks disease progression or new complications that worsen your rating. If you’re stable now, that’s your window.

Common Mistakes That Cost Money

Applying with only one carrier. The client who gets a Table 8 offer from their bank’s insurance partner and accepts it rarely knows that same profile might have received Table 4 from a carrier with better respiratory underwriting. Single carrier applications leave thousands of dollars on the table.

Not disclosing oxygen use accurately. Some applicants mention they “sometimes” use oxygen but don’t specify it’s only during exercise or air travel. Underwriters assume worst case scenarios with vague information. Be specific. Oxygen with exertion only rates several tables better than continuous use.

Assuming whole life or universal life insurance costs too much. Term life insurance makes sense for many ILD clients, but permanent coverage builds cash value that can be accessed if health declines. Some carriers offer better table ratings on permanent products because the policy stays in force longer. Get quotes on both.

Waiting for a cure or significant improvement. ILD typically doesn’t improve dramatically. Waiting for better health usually means waiting forever while getting older and potentially worse. The best time to apply is when you’re stable, regardless of absolute lung function numbers.

Not gathering documentation before applying. When carriers order your medical records directly, they see everything including notes you might not remember. Reviewing your own records first lets you understand what underwriters will see and address any documentation issues proactively.

Interstitial Lung Disease Rates Across Product Types

Table ratings apply similarly across term, whole, and universal life products, but the base premium differences mean your actual costs vary significantly by product type.

Term life insurance rates provide the most affordable coverage for ILD clients who need protection for a specific time period. A 20 year term policy at Table 4 still costs less monthly than whole life at Table 2. If you need coverage until your kids finish college or your mortgage gets paid off, term delivers maximum death benefit for minimum premium even with table ratings applied.

Whole life insurance rates run higher because coverage lasts your entire lifetime and builds guaranteed cash value. For ILD clients, whole life makes sense if you need permanent coverage or want the cash value component as a financial asset. Some carriers rate stable ILD cases more favorably on whole life applications because the extended premium payment period reduces their risk.

Universal life insurance rates fall between term and whole life in cost, offering permanent coverage with flexible premiums and death benefits. The cash value growth in universal life policies depends partly on credited interest rates. For ILD clients, universal life works well if you want coverage that adapts as your financial situation changes while maintaining lifelong protection. For permanent coverage decisions, see our IUL and GUL life insurance with interstitial lung disease for the IUL and GUL paths available with this diagnosis.

The product choice depends on your specific goals, but all three types remain accessible with interstitial lung disease. The table rating affects each product proportionally, so a Table 4 rating costs roughly the same percentage more whether you choose term, whole, or universal coverage.

FAQ

How much more does life insurance cost with interstitial lung disease? Expect to pay 50% to 150% more than standard rates depending on your ILD type and severity. Mild, stable cases might see Table 2 to Table 4 (50% to 100% increase), while moderate cases often land at Table 6 to Table 8 (150% to 200% increase). Advanced ILD with oxygen dependence typically requires guaranteed issue coverage at significantly higher premiums.

Can I get approved for life insurance with interstitial lung disease? Yes, approval is very likely unless you have advanced disease requiring continuous oxygen or you’re listed for lung transplant. Most ILD clients receive table rated approvals between Table 2 and Table 8. The approval question is really about which carrier offers the best rating for your specific situation.

Should I apply now or wait until my condition stabilizes more? Apply when you’re stable, even if your lung function isn’t perfect. Waiting means paying higher premiums due to age increases of 8% to 10% annually, plus you risk disease progression that worsens your rating. If your PFTs have been steady for 12 months, that’s stable enough to shop the market.

What medical records do I need before applying? Gather your most recent pulmonary function tests (within 6 months), chest CT or imaging reports, current medication list, pulmonology visit notes from the past year, and any six minute walk test results. Having documentation ready speeds up underwriting and often results in better classifications because you control the narrative rather than leaving it to record retrieval.

Related health conditions

Readers comparing health conditions and term coverage can also review term life insurance for von willebrand disease, Inflammatory Bowel Disease term life insurance, and Coronary Artery Disease term life insurance.